Advertisement
Screener

GENZYME CORP Patents: Applications Pending, 2020

GENZYME CORP Patent Applications Pending

4 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2020-10-02: Application 63086982; Invention BIPARATOPIC CD73 ANTIBODIES; Applicant GENZYME CORPORATION; Status Provisional Application Expired.
  • 2020-05-12: Application 63023542; Invention BIPARATOPIC CD73 ANTIBODIES; Applicant GENZYME CORPORATION; Status Provisional Application Expired.
  • 2020-02-03: Application PCTUS2020016441; Invention METHODS FOR TREATING SYMPTOMS AND DISORDERS ASSOCIATED WITH LYSOSOMAL STORAGE DISEASES; Applicant GENZYME CORPORATION; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2020-01-17: Application 62962647; Invention METHODS FOR TREATING SYMPTOMS AND DISORDERS ASSOCIATED WITH LYSOSOMAL STORAGE DISEASES; Applicant Genzyme Corporation; Status Provisional Application Expired.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2020-10-0263086982BIPARATOPIC CD73 ANTIBODIESGENZYME CORPORATIONProvisional Application Expired
James E. Stefano
Yenfang Zhou
Dana Lord
Katarina Radosevic
United States
United States
United States
France
2020-05-1263023542BIPARATOPIC CD73 ANTIBODIESGENZYME CORPORATIONProvisional Application Expired
James E. Stefano
Yenfang Zhou
Dana Lord
Katarina Radosevic
United States
United States
United States
France
2020-02-03PCTUS2020016441METHODS FOR TREATING SYMPTOMS AND DISORDERS ASSOCIATED WITH LYSOSOMAL STORAGE DISEASESGENZYME CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
TANYA ZAREMBA FISCHER
NIGEL PATRICK SOMERVILLE CRAWFORD
United States
United States
2020-01-1762962647METHODS FOR TREATING SYMPTOMS AND DISORDERS ASSOCIATED WITH LYSOSOMAL STORAGE DISEASESGenzyme CorporationProvisional Application Expired
Nigel Patrick Somerville CRAWFORD
Tanya Zaremba FISCHER
United States
United States